Australia Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Australia Drug Delivery Devices Market is Segmented by Route of Administration (Injectable, Topical, Ocular, and Other Routes of Administration), Application (Cancer, Cardiovascular, Diabetes, Infectious diseases, and Other Applications), End User (Hospitals, Ambulatory Surgical Centers, and Other End Users). The report offers the value (in USD million) for the above segments.

Australia Drug Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Australia Drug Delivery Devices Industry Overview

The Australian drug delivery device market is fragmented and competitive and consists of several major players. Some of the companies that are currently dominating the market are Viatris Inc. (Mylan N.V.), Novartis AG, GlaxoSmithKline Plc, Becton, Dickinson and Company, AbbVie Inc., Novo Nordisk, Johnson & Johnson, Sanofi AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Bayer AG, and SiBiono GeneTech Co.

Australia Drug Delivery Devices Market Leaders

  1. Novartis AG

  2. GlaxoSmithKline Plc

  3. Becton, Dickinson and Company

  4. Johnson and Johnson

  5. Pfizer, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Australia Drug Delivery Devices Market.png

Australia Drug Delivery Devices Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?